This undated image provided by Blue Origin shows an illustration of the capsule that will be used to take tourists into space. Blue Origin announced Thursday, July 15, 2021, that instead of an auction winner launching with founder Jeff Bezos on Tuesday, Oliver Daemen, 18, will be on board. The company said he'll be the first paying customer, but did not disclose the cost of his ticket. (Blue Origin via AP)
By Marcia Dunn
An 18-year-old is about to become the youngest person in space, rocketing away with an aviation pioneer who will become the oldest at age 82.
Blue Origin announced Thursday that instead of a $28 million auction winner launching with founder Jeff Bezos on Tuesday, Dutch runner-up Oliver Daemen will be on board. The company said he'll be the first paying customer, but did not disclose the price of his ticket.
“I am super excited to experience zero-g and see the world from above," Daemen said in a video posted by Dutch broadcaster RTL.
Also soaring on Blue Origin’s first launch with passengers: Bezos’ brother and Wally Funk, one of 13 female pilots who went through the same studies in the early 1960s as NASA's Mercury 7 astronauts did, but were rejected for being women.
The four will blast off from West Texas atop a New Shepard rocket for a 10-minute flight.
According to Blue Origin, Daemen took a year off after graduating from high school last year to obtain his private pilot’s license. He’ll attend the University of Utrecht in the Netherlands in September.
His father is Joes Daemen, founder and CEO of Somerset Capital Partners, a private equity firm in Oisterwijk, Netherlands. Both father and son are already in the U.S. preparing for the launch, according to a company representative.
“This marks the beginning of commercial operations for New Shepard, and Oliver represents a new generation of people who will help us build a road to space,” Blue Origin CEO Bob Smith said in a statement.
Blue Origin said the yet-to-be-identified winner of the charity auction is stepping aside because of a scheduling conflict and will catch a future flight. Daemen was going to be on the second launch for paying customers.
The company has yet to open ticket sales or disclose its prices to the public. That’s expected following Bezos’ flight.
The Amazon founder will become the second person to ride his own rocket into space, following Virgin Galactic's Richard Branson by nine days.
Soviet cosmonaut Ghermon Titov holds the record for the youngest to fly in space. He was 25 when he blasted into orbit four months after Yuri Gagarin, the first person in space. John Glenn was 77 when he launched aboard space shuttle Discovery in 1998, 37 years after becoming the first American to orbit the world.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
Dr. Rob Davidson, Executive Director of the Committee to Protect Health Care and an ER Physician in West Michigan, joins Cheddar News to break down the expectations of Pfizer's new COVID-19 treatment pill.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
